Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity.
Countagen has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
Countagen's investors include Almi Invest.
Countagen is headquartered in Solna, Sweden.
Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity.
Countagen is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Countagen — Funding & Investors." VCBacked, June 27, 2022, https://www.vcbacked.co/company/countagen. Accessed August 13, 2026.
VCBacked. (2022). Countagen — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/countagen
{{cite web |title=Countagen — Funding & Investors |url=https://www.vcbacked.co/company/countagen |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated